Takeda Pharmaceutical Co (TAKP34)
BOV
Quarter End | 6 2022 | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
総資産 | 14.07T | 14.59T | 13.5T | 13.96T | 14.79T | 14.87T | 14.22T | 9.76T |
流動資産合計 | 2.55T | 2.75T | 2.6T | 2.4T | 2.47T | 2.46T | 2.43T | 730.76B |
現金および同等物 | 645.99B | 798.14B | 685.14B | 533.53B | 316.38B | 318.05B | 288.36B | 130.95B |
非流動資産合計 | 11.52T | 11.84T | 10.91T | 13.25T | 12.32T | 12.41T | 11.79T | 9.03T |
負債合計 | 7.75T | 7.88T | 7.33T | 7.6T | 7.87T | 7.8T | 7.48T | 5.67T |
流動負債合計 | 2.17T | 2.39T | 2.24T | 2.48T | 2.5T | 2.37T | 2.28T | 1.17T |
非流動負債合計 | 9.9T | 9.65T | 9.01T | 9.16T | 9.7T | 9.84T | 9.49T | 8.85T |
普通株 | 3.28T | 3.59T | 3.06T | 1.68T | 1.68T | 3.96T | 3.67T | 1.68T |
留保所得 | 1.46T | 1.53T | 1.51T | 1.54T | 1.49T | 1.45T | 1.4T | 471.27B |
年末 2024年3月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
総資産 | 4.36T | 4.11T | 13.87T | 12.82T | 12.91T | 13.18T | 13.96T | 15.11T |
流動資産合計 | 1.26T | 1.08T | 3.05T | 2.47T | 2.71T | 2.59T | 2.4T | 2.56T |
現金および同等物 | 319.46B | 294.52B | 702.09B | 637.61B | 966.22B | 849.7B | 533.53B | 457.8B |
非流動資産合計 | 1.95T | 2.02T | 5.16T | 4.73T | 5.18T | 5.68T | 6.35T | 7.27T |
負債合計 | 2.41T | 2.09T | 8.71T | 8.09T | 7.74T | 7.49T | 7.6T | 7.83T |
流動負債合計 | 1.37T | 737.51B | 2.51T | 2.18T | 1.77T | 2.15T | 2.48T | 2.31T |
非流動負債合計 | 1.64T | 2.34T | 10.96T | 10.42T | 10.58T | 9.49T | 9.16T | 10T |
総資本 | 1.95T | 2.02T | 5.16T | 4.73T | 5.18T | 5.68T | 6.35T | 7.27T |
普通株 | 65.2B | 77.91B | 2T | 1.76T | 2.03T | 2.61T | 3.18T | 1.68T |
留保所得 | 1.51T | 1.56T | 1.57T | 1.37T | 1.51T | 1.48T | 1.54T | 1.39T |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約